FDAnews
www.fdanews.com/articles/102500-r1507-antibody-to-enter-phase-ii-study

R1507 Antibody to Enter Phase II Study

December 20, 2007
Genmab A/S announced that its partner Roche has initiated a Phase II clinical study of R1507 for the treatment of recurrent or refractory sarcoma.
Yahoo! Finance